EGFR and non-small cell lung carcinoma: This review aims to meticulously summarize the outcomes of multimodal omics analyses of the EGFR signaling pathway in NSCLC, assess the efficacy and limitations of existing EGFR-targeted therapies, and discuss innovative therapeutic strategies based on omics data.